Skip to main content
SpringerLink
Log in

Although pharmacological treatment may have beneficial effects in some patients with dementia, it does not reverse the disease process

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Dementia is a complex progressive disorder characterized by changes in personality, cognitive impairment and diminished activities of daily living. Early detection and treatment of symptoms is important. Although there is currently no treatment that reverses the disease process, acetylcholinesterase inhibitors are the mainstay of pharmacological treatment for cognitive symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Holzer S, Warner JP, Iliffe S. Diagnosis and management of the patient with suspected dementia in primary care. Drugs Aging. 2013;30(9):667–76.

    Article  CAS  PubMed  Google Scholar 

  2. World Alzheimer Report 2009. London: Alzheimer’s Disease International; 2010.

  3. Rodda J, Carter J. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ. 2012;344:e2986.

    Article  PubMed  Google Scholar 

  4. Dementia: supporting people with dementia and their carers in health and social care: NICE clinical guideline 42. Manchester: National Institute for Health and Clinical Excellence; 2012.

  5. Small G, Bullock R. Defining optimal treatment with cholinesterase inhibitors in Alzheimer’s disease. Alzheimers Dement. 2011;7(2):177–84.

    Article  CAS  PubMed  Google Scholar 

  6. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of NICE technology appraisal guidance 111): NICE technology appraisal guidance 217. London: National Institute for Health and Clinical Excellence; 2011.

  7. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary (September 2013). London: BMJ Group and the Royal Pharmaceutical Society; 2013.

  8. Warner J, Butler R, Gupta S. Dementia. Clin Evid (Online). 2010;pii: 1001.

  9. Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med. 2012;366(10):893–903.

    Article  CAS  PubMed  Google Scholar 

  10. Bains J, Birks JS, Dening TR. The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database Syst Rev. 2002(4):CD003944.

  11. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–72.

    Article  CAS  PubMed  Google Scholar 

  12. Woods B, Aguirre E, Spector AE, et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;2:CD005562.

    Google Scholar 

  13. Rowland JP, Rigby J, Harper AC, et al. Cardiovascular monitoring with acetylcholinesterase inhibitors: a clinical protocol. Adv Psychiatr Treat. 2007;13:178–84.

    Article  Google Scholar 

  14. Hansen RA, Gartlehner G, Webb AP, et al. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clin Interv Aging. 2008;3(2):211–25.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Disclosure

This article was adapted from Drugs & Aging 2013;30(9):667–76 [1]. The preparation of these articles was not supported by any external funding.

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Adis Medical Writers. Although pharmacological treatment may have beneficial effects in some patients with dementia, it does not reverse the disease process. Drugs Ther Perspect 30, 130–134 (2014). https://doi.org/10.1007/s40267-014-0110-z

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-014-0110-z

    Search

    Navigation